Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Medroxyprogesterone price, strengths & recalls

Generic of Depo-Provera, depo-subQ provera

Pharmacies pay $4.58 for 30 tablets of Medroxyprogesterone 10 mg tablet this week, and from $3.45 to $26.90 across its 5 priced strengths and forms. 23 manufacturers make it. It is in shortage (being discontinued). 5 recalls are ongoing. Its official label last changed on July 24, 2024.

Being discontinued5 open recallsGeneric
Pharmacies pay$4.58for 30 tablets of 10 mg tablet+0.2% in 4 weeks
Fair cash price
$15.77
Strengths
5
Makers
23
Updated
Nov 11

Medroxyprogesterone price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
150 mg/mL, 1 mL injection$17.86$17.86 / 1 mL-5.3%-18.5%
150 mg/mL, 1 mL prefilled syringe$26.90$26.90 / 1 mL-1.7%-17.4%
2.5 mg tablet$0.1149$3.45 / 30 tablets-0.6%-3.4%
5 mg tablet$0.1395$4.18 / 30 tablets-2.3%-5.6%
10 mg tablet$0.1526$4.58 / 30 tablets+0.2%+0.1%

The lowest cost per tablet is 2.5 mg tablet at $0.1149. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Brand names of medroxyprogesterone

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

In shortage2 products are short or being discontinued
5 ongoing recalls33 recalls on record, latest May 7, 2025

Shortages

  • PROVERA, Tablet, 10 mg (NDC 0009-0051-01)Pfizer Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026Discontinuation of the manufacture of the drug; Withdrawal from sale expected September 2026.
  • PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)Pfizer Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026.

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 33 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for medroxyprogesterone? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJuly 24, 2024
Version1012 of 8
EffectiveJul 8, 2024
Read the label

MedroxyPROGESTERone Acetate Tablets, USP

This drug has a boxed warning

WARNING: CARDIOVASCULAR DISORDERS, BREAST CANCER AND PROBABLE DEMENTIA FOR ESTROGEN PLUS PROGESTIN THERAPY

Cardiovascular Disorders and Probable Dementia

Estrogen plus progestin therapy should not be used for the prevention of cardiovascular disease or dementia. (See CLINICAL STUDIES and WARNINGS, Cardiovascular Disorders and Probable Dementia.)

The Women's Health Initiative (WHI) estrogen plus progestin substudy reported an increased risk of deep vein thrombosis (DVT), pulmonary embolism (PE), stroke and myocardial infarction (MI) in postmenopausal women (50 to 79 years of age) during 5.6 years of treatment with daily oral conjugated estrogens (CE) [0.625 mg] combined with medroxyprogesterone acetate (MPA) [2.5 mg], relative to placebo. (See CLINICAL STUDIES and WARNINGS, Cardiovascular Disorders.)

The WHI Memory Study (WHIMS) estrogen plus progestin ancillary study reported an increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with daily CE (0.625 mg) combined with MPA (2.5 mg), relative to placebo. It is unknown whether this finding applies to younger postmenopausal women. (See CLINICAL STUDIES and WARNINGS, Probable Dementia and PRECAUTIONS, Geriatric Use.)

Breast Cancer

The WHI estrogen plus progestin substudy demonstrated an increased risk of invasive breast cancer. (See CLINICAL STUDIES and WARNINGS,Malignant Neoplasm,Breast Cancer.)

In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA, and other combinations and dosage forms of estrogens and progestins.

Progestins with estrogens should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA011839 · Pfizer
First approved
June 18, 1959 (67 years ago)
Latest approved change
February 15, 2024
Approved label
PDF, Feb 20, 2024
Generic makers
10 approved generic applications on the market

Medroxyprogesterone questions

How much does medroxyprogesterone cost without insurance?

Pharmacies pay about $4.58 for 30 tablets of medroxyprogesterone 10 mg tablet ($0.1526 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $15.77. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of medroxyprogesterone?

Medroxyprogesterone is sold as Depo-Provera, depo-subQ provera. The generic has the same active ingredient and usually costs far less.

Is medroxyprogesterone in shortage?

Yes. 2 products are listed as in shortage or being discontinued (being discontinued). See which ones.

Has medroxyprogesterone been recalled?

33 recalls on record, 5 ongoing. Recalls name specific lots - check yours.

When did the medroxyprogesterone label last change?

The official label was last updated on July 24, 2024 (version 1012). See what changed.

Talk about medroxyprogesterone

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.